Huadong Medicine Co Ltd Cash Flow Conversion Efficiency
Huadong Medicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Huadong Medicine Co Ltd (000963) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥155.98 Million ≈ $22.82 Million USD) by net assets (CN¥24.50 Billion ≈ $3.58 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Huadong Medicine Co Ltd (1998–2024)
Cash flow conversion efficiency of Huadong Medicine Co Ltd from 1998 to 2024. This chart illustrates how Huadong Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Huadong Medicine Co Ltd (000963) share price today for real-time trading data and today's change.
Huadong Medicine Co Ltd Cash Flow Conversion Ratio Explained
Huadong Medicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Huadong Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huadong Medicine Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Huadong Medicine Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stora Enso Oyj R
HE:STERV
|
0.003x |
|
Yealink Network Technology Corp Ltd
SHE:300628
|
0.059x |
|
Huali Industrial Group Company Limited
SHE:300979
|
0.144x |
|
CAVA Group, Inc.
NYSE:CAVA
|
0.052x |
|
Merus BV
NASDAQ:MRUS
|
-0.128x |
|
FormFactor Inc
NASDAQ:FORM
|
0.056x |
|
Hellenic Telecommunications Organization S.A
AT:HTO
|
0.117x |
|
Leader Harmonious Drive Systems Co Ltd
SHG:688017
|
0.021x |
Annual Cash Flow Conversion Efficiency for Huadong Medicine Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Huadong Medicine Co Ltd from 1998 to 2024. Review Huadong Medicine Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥23.56 Billion ≈ $3.45 Billion |
CN¥3.75 Billion ≈ $548.59 Million |
0.159x | -12.61% |
| 2023-12-31 | CN¥21.58 Billion ≈ $3.16 Billion |
CN¥3.93 Billion ≈ $574.97 Million |
0.182x | +46.58% |
| 2022-12-31 | CN¥19.18 Billion ≈ $2.81 Billion |
CN¥2.38 Billion ≈ $348.54 Million |
0.124x | -33.62% |
| 2021-12-31 | CN¥16.94 Billion ≈ $2.48 Billion |
CN¥3.17 Billion ≈ $463.84 Million |
0.187x | -16.75% |
| 2020-12-31 | CN¥15.18 Billion ≈ $2.22 Billion |
CN¥3.41 Billion ≈ $499.20 Million |
0.225x | +44.46% |
| 2019-12-31 | CN¥12.87 Billion ≈ $1.88 Billion |
CN¥2.00 Billion ≈ $292.91 Million |
0.156x | -20.47% |
| 2018-12-31 | CN¥10.43 Billion ≈ $1.53 Billion |
CN¥2.04 Billion ≈ $298.44 Million |
0.196x | +3.74% |
| 2017-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
CN¥1.66 Billion ≈ $243.07 Million |
0.189x | +6.99% |
| 2016-12-31 | CN¥7.64 Billion ≈ $1.12 Billion |
CN¥1.35 Billion ≈ $197.10 Million |
0.176x | -13.19% |
| 2015-12-31 | CN¥3.24 Billion ≈ $474.60 Million |
CN¥658.54 Million ≈ $96.36 Million |
0.203x | -30.97% |
| 2014-12-31 | CN¥2.52 Billion ≈ $368.56 Million |
CN¥740.85 Million ≈ $108.41 Million |
0.294x | +85.94% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.21 Million |
CN¥476.98 Million ≈ $69.80 Million |
0.158x | -42.36% |
| 2012-12-31 | CN¥2.34 Billion ≈ $342.72 Million |
CN¥642.73 Million ≈ $94.05 Million |
0.274x | +2954.34% |
| 2011-12-31 | CN¥1.79 Billion ≈ $262.60 Million |
CN¥16.12 Million ≈ $2.36 Million |
0.009x | +143.20% |
| 2010-12-31 | CN¥1.35 Billion ≈ $196.94 Million |
CN¥-27.99 Million ≈ $-4.10 Million |
-0.021x | -104.74% |
| 2009-12-31 | CN¥1.29 Billion ≈ $189.31 Million |
CN¥567.94 Million ≈ $83.11 Million |
0.439x | +13.71% |
| 2008-12-31 | CN¥892.80 Million ≈ $130.64 Million |
CN¥344.69 Million ≈ $50.44 Million |
0.386x | -0.61% |
| 2007-12-31 | CN¥684.27 Million ≈ $100.13 Million |
CN¥265.79 Million ≈ $38.89 Million |
0.388x | +393.01% |
| 2006-12-31 | CN¥728.30 Million ≈ $106.57 Million |
CN¥57.38 Million ≈ $8.40 Million |
0.079x | -73.38% |
| 2005-12-31 | CN¥686.99 Million ≈ $100.53 Million |
CN¥203.33 Million ≈ $29.75 Million |
0.296x | +1435.72% |
| 2004-12-31 | CN¥648.91 Million ≈ $94.96 Million |
CN¥12.51 Million ≈ $1.83 Million |
0.019x | -86.42% |
| 2003-12-31 | CN¥637.95 Million ≈ $93.35 Million |
CN¥90.54 Million ≈ $13.25 Million |
0.142x | +260.25% |
| 2002-12-31 | CN¥607.81 Million ≈ $88.94 Million |
CN¥23.94 Million ≈ $3.50 Million |
0.039x | -79.24% |
| 2001-12-31 | CN¥578.05 Million ≈ $84.59 Million |
CN¥109.67 Million ≈ $16.05 Million |
0.190x | +400.09% |
| 2000-12-31 | CN¥516.34 Million ≈ $75.56 Million |
CN¥19.59 Million ≈ $2.87 Million |
0.038x | -66.12% |
| 1999-12-31 | CN¥502.91 Million ≈ $73.59 Million |
CN¥56.32 Million ≈ $8.24 Million |
0.112x | +5.70% |
| 1998-12-31 | CN¥224.63 Million ≈ $32.87 Million |
CN¥23.80 Million ≈ $3.48 Million |
0.106x | -- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more